Ability of Candida albicans Mutants To Induce Staphylococcus aureus Vancomycin Resistance during Polymicrobial Biofilm Formation

ABSTRACT Candida albicans and Staphylococcusaureus form vigorous polymicrobial biofilms in serum, which may serve as the source of coinfection in patients. More importantly, S. aureus is highly resistant to vancomycin during polymicrobial biofilm formation, with no decreases in bacterial viability observed with up to 1,600 μg/ml drug. In these mixed-species biofilms, S. aureus preferentially associates with C. albicans hyphae, which express a variety of unique adhesins. We tested C. albicans mutants deficient in transcriptional regulators of morphogenesis (CPH1 and EFG1) and biofilm formation (BCR1) to investigate the role of hyphae in mediating polymicrobial biofilm formation. These mutants also have reduced expression of hypha-specific adhesins. The ability to form polymicrobial biofilms correlated with the ability to form hyphae in these mutants. However, only mutants that could adhere to the abiotic surface could induce S. aureus vancomycin resistance, regardless of the presence of hyphae. In examining factors that may mediate interspecies adhesion, we found that the C. albicans ALS family of adhesins (Als1 to Als7 and Als9) was not involved, and neither was the hypha-specific adhesin Hwp1. Therefore, polymicrobial biofilm formation and subsequent antibiotic resistance is a multifactorial process that may require a unique combination of fungal and/or bacterial adhesins.

[1]  Xiaomin Zhao,et al.  Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit. , 2008, Medical mycology.

[2]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[3]  A. Mitchell,et al.  Candida albicans RIM101 pH Response Pathway Is Required for Host-Pathogen Interactions , 2000, Infection and Immunity.

[4]  G. Fink,et al.  Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. , 1994, Science.

[5]  D. Andes,et al.  Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model , 2004, Infection and Immunity.

[6]  A. Mitchell,et al.  Regulation of Cell-Surface Genes and Biofilm Formation by the C. albicans Transcription Factor Bcr1p , 2005, Current Biology.

[7]  Xiaomin Zhao,et al.  Unequal contribution of ALS9 alleles to adhesion between Candida albicans and human vascular endothelial cells. , 2007, Microbiology.

[8]  K. Nickerson,et al.  Quorum Sensing in Dimorphic Fungi: Farnesol and Beyond , 2006, Applied and Environmental Microbiology.

[9]  Marco M. Kessler,et al.  Identification of potential cell‐surface proteins in Candida albicans and investigation of the role of a putative cell‐surface glycosidase in adhesion and virulence , 2004, Yeast.

[10]  E. Carlson.  Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice , 1983, Infection and immunity.

[11]  Yee-Chun Chen,et al.  Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway , 2002, Molecular microbiology.

[12]  Xiaomin Zhao,et al.  Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. , 2005, Microbiology.

[13]  K. Kurokawa,et al.  Contribution of the Mannan Backbone of Cryptococcal Glucuronoxylomannan and a Glycolytic Enzyme of Staphylococcus aureus to Contact-Mediated Killing of Cryptococcus neoformans , 2007, Journal of bacteriology.

[14]  J. Sobel,et al.  Adherence of Candida albicans to human vaginal and buccal epithelial cells. , 1981, The Journal of infectious diseases.

[15]  E. Carlson,et al.  Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice , 1985, Infection and immunity.

[16]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  P. Lipke,et al.  Candida albicans Als proteins mediate aggregation with bacteria and yeasts. , 2007, Medical mycology.

[18]  E. Carlson,et al.  Synergism of Candida albicans and delta toxin producing Staphylococcus aureus on mouse mortality and morbidity: protection by indomethacin. , 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[19]  Gordon Ramage,et al.  The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. , 2002, FEMS microbiology letters.

[20]  E. Carlson,et al.  Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity , 1983, Infection and immunity.

[21]  A. Mitchell,et al.  Complementary Adhesin Function in C. albicans Biofilm Formation , 2008, Current Biology.

[22]  J. Mallet,et al.  β‐1,2‐linked oligomannosides Inhibit Candida albicans binding to murine macrophage , 1996, Journal of leukocyte biology.

[23]  J. Nuessen,et al.  ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. , 2004, Microbiology.

[24]  R. Calderone,et al.  Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro , 1980, Infection and immunity.

[25]  N. Gow,et al.  Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa , 2008, FEMS microbiology letters.

[26]  D. Underhill,et al.  Dectin‐1 mediates macrophage recognition of Candida albicans yeast but not filaments , 2005, The EMBO journal.

[27]  A. Widmer,et al.  Intravascular catheter-associated infections. , 1997, Schweizerische medizinische Wochenschrift.

[28]  S. Stepanović,et al.  A modified microtiter-plate test for quantification of staphylococcal biofilm formation. , 2000, Journal of microbiological methods.

[29]  E. Carlson,et al.  Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality , 1982, Infection and immunity.

[30]  P. Lipke,et al.  Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. , 2007, Diagnostic microbiology and infectious disease.

[31]  Xiaomin Zhao,et al.  Deletion of ALS5, ALS6 or ALS7 increases adhesion of Candida albicans to human vascular endothelial and buccal epithelial cells. , 2007, Medical mycology.

[32]  A. Mitchell,et al.  Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo , 2006, PLoS pathogens.

[33]  M. Harriott,et al.  Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance , 2009, Antimicrobial Agents and Chemotherapy.

[34]  A. Mitchell,et al.  Function of Candida albicans Adhesin Hwp1 in Biofilm Formation , 2006, Eukaryotic Cell.

[35]  J. Pinon,et al.  FTIR spectroscopy as a potential tool to analyse structural modifications during morphogenesis of Candida albicans , 2006, Archives of Microbiology.

[36]  R. Walmsley,et al.  Developmental Regulation of an Adhesin Gene during Cellular Morphogenesis in the Fungal Pathogen Candida albicans , 2007, Eukaryotic Cell.